DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > School of Tropical Medicine and Global Health > Articles in academic journal >

Selective Cytotoxicity of Dihydroorotate Dehydrogenase Inhibitors to Human Cancer Cells Under Hypoxia and Nutrient-Deprived Conditions


File Description SizeFormat
FiPha9_997.pdf2.38 MBAdobe PDFView/Open

Title: Selective Cytotoxicity of Dihydroorotate Dehydrogenase Inhibitors to Human Cancer Cells Under Hypoxia and Nutrient-Deprived Conditions
Authors: Miyazaki, Yukiko / Inaoka, Daniel K. / Shiba, Tomoo / Saimoto, Hiroyuki / Sakura, Takaya / Amalia, Eri / Kido, Yasutoshi / Sakai, Chika / Nakamura, Mari / Moore, Anthony L. / Harada, Shigeharu / Kita, Kiyoshi
Issue Date: 4-Sep-2018
Publisher: Frontiers Media S.A.
Citation: Frontiers in Pharmacology, 9, art.no.997; 2018
Abstract: Human dihydroorotate dehydrogenase (HsDHODH) is a key enzyme of pyrimidine de novo biosynthesis pathway. It is located on the mitochondrial inner membrane and contributes to the respiratory chain by shuttling electrons to the ubiquinone pool. We have discovered ascofuranone (1), a natural compound produced by Acremonium sclerotigenum, and its derivatives are a potent class of HsDHODH inhibitors. We conducted a structure-activity relationship study and have identified functional groups of 1 that are essential for the inhibition of HsDHODH enzymatic activity. Furthermore, the binding mode of 1 and its derivatives to HsDHODH was demonstrated by co-crystallographic analysis and we show that these inhibitors bind at the ubiquinone binding site. In addition, the cytotoxicities of 1 and its potent derivatives 7, 8, and 9 were studied using human cultured cancer cells. Interestingly, they showed selective and strong cytotoxicity to cancer cells cultured under microenvironment (hypoxia and nutrient-deprived) conditions. The selectivity ratio of 8 under this microenvironment show the most potent inhibition which was over 1000-fold higher compared to that under normal culture condition. Our studies suggest that under microenvironment conditions, cancer cells heavily depend on the pyrimidine de novo biosynthesis pathway. We also provide the first evidence that 1 and its derivatives are potential lead candidates for drug development which target the HsDHODH of cancer cells living under a tumor microenvironment.
Keywords: Anticancer activity / Ascofuranone / Crystal structure / Pyrimidine de novo biosynthesis / Structure-activity relationship / Tumor bioenergetics / Tumor microenvironment / Ubiquinone binding-site inhibitor
URI: http://hdl.handle.net/10069/38616
DOI: 10.3389/fphar.2018.00997
Rights: © 2018 Miyazaki, Inaoka, Shiba, Saimoto, Sakura, Amalia, Kido, Sakai, Nakamura, Moore, Harada and Kita. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Type: Journal Article
Text Version: publisher
Appears in Collections:Articles in academic journal

Citable URI : http://hdl.handle.net/10069/38616

All items in NAOSITE are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace